Qube Research & Technologies LTD Xeris Biopharma Holdings, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 23,903 shares of XERS stock, worth $70,752. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,903
Previous 178,562
86.61%
Holding current value
$70,752
Previous $394,000
86.55%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding XERS
# of Institutions
133Shares Held
57MCall Options Held
126KPut Options Held
45K-
Black Rock Inc. New York, NY10.3MShares$30.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.66MShares$22.7 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$15.1 Million61.49% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.83MShares$14.3 Million1.75% of portfolio
-
State Street Corp Boston, MA3.26MShares$9.65 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $402M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...